Accreditation Statistics

As of October 1, 2023

Cellular Therapy Entities

  • Accredited: 258
  • Applicants: 26

Cord Blood Banks

  • Accredited: 53
  • Applicants: 9

Congratulations to the following programs for achieving initial FACT accreditation:

  • Kingston Health Sciences Centre
  • CTCA-COH Arizona Hematologic Malignancy and Cellular Therapy Institute (CAHCTI)
  • The Good Samaritan Hospital of Cincinnati, Ohio

A complete list of accredited organizations can be found at www.factglobal.org.

IEC Webinar Series: Solid Tumors

Posted in :: 2022 Volume 2 :: Friday, June 17th, 2022

General Concepts and Need for Harmonization of Standards
September 28, 2022

Join us on Wednesday, September 28, 2022, at 11:00 am ET/15:00 GMT, for the FACT IEC Webinar: General Concepts and Need for Harmonization of Standards. Basem William, MD, MRCP, FACP, from Ohio Health Blood and Marrow Transplant and Cellular Therapy Program, and Sarah Nikiforow, MD, PhD, from Dana-Farber Cancer Institute / Cell Manipulation Core Facility, will discuss the following:

  • Introduction to IEC in solid tumors
  • Unique challenges with IEC in solid tumors
  • Subtypes of IEC in solid tumors; TIL, CAR-T, TCR, others
  • Unique consideration in solid tumor IEC manufacturing
  • Need for harmonization of IEC standards; how FACT can help

Register now


Tumor Infiltrating Lymphocytes
January 17, 2023

Join us on Tuesday, January 17, 2023, at 11:00 am ET/16:00 GMT, for the FACT IEC Webinar: Tumor Infiltrating Lymphocytes. Parameswaran Hari, MD, MRCP, DRCPath, MS, from Iovance Biotherapeutics, and John Mullinax, MD, from H. Lee Moffitt Cancer Center & Research Institute Blood and Marrow Transplant Program, will discuss the following:

  • Introduction to TIL therapy?
  • Review of current clinical experience with TIL
  • Unique consideration in TIL manufacturing
  • Need for establishing safety and efficacy quality benchmarks for TIL; how FACT can help

Register now


Other webinars in this series include:

CAR-T Cells and T-Cell Receptor Cells (TCR) in Solid Tumors (Date TBD)